- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-696/19: Action brought on 14 October 2019 – Teva Pharmaceutical Industries v EUIPO (Moins de migraine pour vivre mieux)
ECLI:EU:UNKNOWN:62019TN0696
62019TN0696
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
EN
Official Journal of the European Union
C 413/60
—
(Case T-696/19)
(2019/C 413/72)
Language of the case: English
Parties
Applicant: Teva Pharmaceutical Industries Ltd (Jerusalem, Israel) (represented by: J. Bogatz and Y. Stone, lawyers)
Defendant: European Union Intellectual Property Office (EUIPO)
Details of the proceedings before EUIPO
Trade mark at issue: Application for European Union word mark Moins de migraine pour vivre mieux – Application for registration No 17 942 393
Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 12 August 2019 in Case R 778/2019-5
Form of order sought
The applicant claims that the Court should:
—annul the contested decision;
—order EUIPO to pay the costs incurred by the applicant.
Plea in law
Infringement of Article 7(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.
—